Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2345424 | 0.87 | PTGS2 (0.43) | SMN1; SMN2ALDH1A1MAPK1TSHRTDP1 | |
| SCHEMBL1462180 | 0.85 | CYP3A4 (0.43) | SMN1; SMN2ALDH1A1MAPK1TSHRTDP1 | |
| SCHEMBL5042607 | 0.81 | CYP3A4 (0.40) | SMN1; SMN2ALDH1A1MAPK1TSHRTDP1 | |
| SCHEMBL21342461 | 0.80 | TAAR1 (0.42) | SMN1; SMN2ALDH1A1MAPK1TSHRTDP1 | |
| SCHEMBL30207369 | 0.80 | CYP3A4 (0.39) | SMN1; SMN2ALDH1A1MAPK1TSHRTDP1 | |
| SCHEMBL21342460 | 0.79 | KMT2A (0.44) | SMN1; SMN2ALDH1A1MAPK1TSHRTDP1 | |
| Malonic Acid Diethyl Ester SCHEMBL7992219 | 0.79 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1MAPK1TSHRTDP1 | |
| 1,3,5-Trimethoxybenzene SCHEMBL27728377 | 0.75 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1MAPK1TSHRTDP1 | |
| SCHEMBL20581598 | 0.74 | ALDH1A1 (0.44) | SMN1; SMN2ALDH1A1MAPK1TSHRTDP1 | |
| SCHEMBL20581597 | 0.74 | ALDH1A1 (0.44) | SMN1; SMN2ALDH1A1MAPK1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1567498-B1 | MANDELIC ACID DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2008-01-23 | — | — | EP | disclosed |
| US-7129238-B2 | Mandelic acid derivatives | HOFFMANN-LA ROCHE INC. (US) | 2006-10-31 | — | — | US | disclosed |
| EP-1567498-A2 | MANDELIC ACID DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2005-08-31 | — | — | EP | disclosed |
| US-20040122057-A1 | Novel mandelic acid derivatives | HOFFMANN-LA ROCHE INC. | 2004-06-24 | — | — | US | disclosed |
| WO-2004048335-A2 | MANDELIC ACID DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2004-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040122057-A1 | Novel mandelic acid derivatives | F7, F11, F9 | SMN1; SMN2 3242/4885ALDH1A1 519/4885MAPK1 401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.